Ste Strt Hlt Cr-SBI
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Trend Stats
1-Month Return
-3.18%
3-Month Return
+0.06%
12-Month Return
+4.09%
Volatility Score
1.5
RSI
38.0
ST Trend
Down
LT Trend
Up
Short-Term Trend
Down
The Short-Term Trend is a metric that gauges an ETF's short-term price trend.
Long-Term Trend
Up
The Long-Term Trend is a metric that gauges an ETF's long-term price trend.
Performance
Ste Strt Hlt Cr-SBI
S&P 500 Index
Components
| Symbol | Company | Market Cap | 12 mo return Performance over the past 12 months | 3 mo return Performance over the past 3 months | 1 mo return Performance over the past month | Vol Score Our gauge of the ETF's recent volatility | ST Trend A metric that gauges an ETF's short-term price trend | LT Trend A metric that gauges an ETF's long-term price trend |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly & Co | $878B | +14.73% | -1.81% | -6.26% | 3.7 | Down | Up |
| JNJ | Johnson&Johnson | $577B | +48.24% | +19.68% | +0.70% | 1.8 | Up | Up |
| ABBV | AbbVie | $411B | +10.98% | +2.60% | +2.99% | 2.5 | Neutral | Up |
| MRK | Merck | $287B | +26.93% | +17.11% | -5.04% | 2.7 | Neutral | Up |
| UNH | Unitedhealth Gro | $262B | -40.52% | -12.84% | +3.55% | 2.9 | Down | Down |
| AMGN | Amgen | $198B | +17.32% | +12.79% | -3.18% | 2.6 | Up | Up |
| TMO | Thermo Fisher Sc | $195B | -5.26% | -12.30% | -7.53% | 2.9 | Down | Down |
| ABT | Abbott Laborator | $193B | -18.61% | -11.96% | -1.15% | 1.8 | Down | Down |
| GILD | Gilead Sciences | $180B | +26.01% | +19.52% | -5.62% | 2.9 | Up | Up |
| ISRG | Intuitive Surgic | $176B | -5.42% | -14.81% | +0.41% | 2.6 | Down | Down |
| PFE | Pfizer | $151B | +8.54% | +5.66% | -0.62% | 2.2 | Up | Up |
| DHR | Danaher | $143B | -7.23% | -13.47% | -9.75% | 2.8 | Down | Down |
| SYK | Stryker | $142B | -3.00% | +0.40% | +1.75% | 2.5 | Down | Down |
| BMY | Bristol-MyersSqu | $124B | +3.68% | +16.98% | -2.74% | 2.5 | Up | Up |
| HCA | HCA Healthcare | $120B | +62.59% | +9.64% | +6.20% | 2.8 | Up | Up |
| MDT | Medtronic | $119B | -0.78% | -9.66% | -11.66% | 2.5 | Down | Down |
| VRTX | Vertex Pharmaceu | $117B | -6.47% | +0.27% | -4.44% | 3.2 | Down | Up |
| MCK | Mckesson | $114B | +43.26% | +13.78% | -3.02% | 3.4 | Up | Up |
| BSX | Boston Scientifi | $108B | -28.02% | -26.84% | -6.45% | 2.9 | Down | Down |
| CVS | CVS Health | $100B | +21.95% | +3.88% | -0.55% | 3.1 | Down | Up |
| REGN | Regeneron Pharma | $79B | +7.99% | +5.90% | -3.15% | 3.1 | Down | Up |
| CI | The Cigna | $74B | -13.59% | +2.90% | -6.48% | 3.1 | Down | Down |
| COR | Cencora | $70B | +41.81% | +5.72% | -0.05% | 3.1 | Neutral | Up |
| ELV | Elevance Health | $63B | -27.89% | -12.43% | -14.56% | 4.2 | Down | Down |
| ZTS | Zoetis-A | $52B | -27.69% | +2.78% | -4.70% | 3.3 | Down | Down |
| CAH | Cardinal Health | $51B | +74.32% | +9.80% | -3.77% | 2.9 | Neutral | Up |
| IDXX | IDEXX Labs | $49B | +41.45% | -14.80% | -5.62% | 3.2 | Down | Down |
| EW | Edwards Lifescns | $49B | +16.08% | -5.28% | +3.72% | 3.1 | Down | Neutral |
| BDX | Becton Dickinson | $48B | -25.62% | -13.37% | -20.43% | 4.2 | Down | Down |
| RMD | Resmed | $37B | +9.77% | -1.21% | -6.69% | 2.9 | Down | Down |
| GEHC | GE Hltc Tech | $35B | -14.06% | -13.06% | -7.91% | 3.7 | Down | Down |
| A | Agilent Tech | $33B | -8.45% | -20.77% | -11.20% | 3.2 | Down | Down |
| WAT | Waters | $31B | -23.02% | -23.37% | -20.65% | 4.6 | Down | Down |
| IQV | IQVIA Holdings | $30B | -8.94% | -22.74% | -6.93% | 5.2 | Down | Down |
| BIIB | Biogen | $28B | +22.94% | +1.97% | -8.11% | 3.3 | Neutral | Up |
| DXCM | Dexcom | $27B | -12.51% | +3.99% | -2.67% | 3.7 | Down | Down |
| MTD | Mettler Toledo I | $26B | -6.34% | -14.50% | -11.93% | 3.1 | Down | Down |
| STE | STERIS | $23B | +0.03% | -12.22% | -8.35% | 3.3 | Down | Down |
| LH | Labcorp Hldgs | $23B | +7.72% | +4.63% | -2.47% | 2.8 | Neutral | Neutral |
| DGX | Quest Diagnostic | $22B | +15.58% | +9.65% | +4.46% | 2.6 | Up | Up |
| 0 | 0 | 0 | 0 | Bullish | Bullish |